-
- Antigène Voir toutes CD55 Anticorps
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp CD55 est conjugé à/à la FITC
-
Application
- Flow Cytometry (FACS)
- Purification
- The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions. The solution is free of unconjugated FITC.
- Clone
- JS11
- Isotype
- IgG1 kappa
- Top Product
- Discover our top product CD55 Anticorps primaire
-
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibody
CD55 Reactivité: Humain WB, ELISA, PLA Hôte: Souris Monoclonal 1G3 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-285) antibodyCD55 Reactivité: Humain WB, ELISA, IHC (fro), ICC, IHC (p) Hôte: Lapin Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 40-300) antibodyCD55 Reactivité: Humain WB, IF Hôte: Lapin Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 51-79) antibodyCD55 Reactivité: Humain WB, FACS, IHC, IF, ELISA Hôte: Lapin Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (Center) antibodyCD55 Reactivité: Humain WB, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibodyCD55 Reactivité: Humain WB, IF, ELISA Hôte: Souris Monoclonal 1D7 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) antibodyCD55 Reactivité: Humain, Non-Human Primate WB, FACS, IP, IHC (p) Hôte: Souris Monoclonal MEM-118 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 254-372) antibodyCD55 Reactivité: Rat WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-126) antibodyCD55 Reactivité: Humain IHC, IF, ELISA Hôte: Lapin Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) antibody (Biotin)CD55 Reactivité: Humain, Non-Human Primate WB, FACS, IP, IHC (p) Hôte: Souris Monoclonal MEM-118 Biotin
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Protect from prolonged exposure to light. Do not freeze.
- Stock
- 4 °C
- Stockage commentaire
- The antibody solution should be stored undiluted between 2°C and 8°C.
-
- Antigène
- CD55 (Complement Decay-Accelerating Factor (CD55))
- Autre désignation
- CD55 (CD55 Produits)
- Synonymes
- anticorps CR, anticorps CROM, anticorps DAF, anticorps TC, anticorps Daf, anticorps Daf-GPI, anticorps Daf1, anticorps GPI-DAF, anticorps CD55 molecule (Cromer blood group), anticorps CD55 molecule, decay accelerating factor for complement, anticorps CD55, anticorps Cd55
- Sujet
- CD55 is a 60-70 kD glycosylphosphatidylinositol (GPI)-anchored single chain glycoprotein also known as decay-accelerating factor (DAF). It is expressed on hematopoietic cells including erythrocytes and many non-hematopoietic cells. CD55 accelerates the dissociation of the components of the C3-convertases (namely C2a from C4b in the C4bC2a complex, a C3-convertase of the classical pathway, and factor Bb from the C3bBb complex, a C3-convertase of the alternative pathway) to protect cells from inappropriate damage caused by autologous complement. CD55 has been reported to reduce the efficiency of NK cell lysis and induce signal transduction in T cells. CD55 has also been shown to interact with CD97 and bind to Coxsackie and Echovirus.
- Pathways
- Système du Complément, Regulation of Leukocyte Mediated Immunity
-
Vous êtes ici:
